NCT00722735View on ClinicalTrials.gov

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Urinary Tract Infections
Interventions
DRUG

Finafloxacin

Finafloxacin tablets, 300 mg b.i.d., oral administration; Ciprofloxacin placebo capsule, 1 capsule b.i.d.,oral administration; duration: 3 days

DRUG

Ciprofloxacin

Finafloxacin placebo, 6 tablets b.i.d., oral administration; Ciprofloxacin capsule, 250 mg b.i.d., oral administration; duration: 3 days

Trial Locations (2)

35037

Medical practice, Dr. J. Hein (Principal Study Investigator), Marburg

119074

National University Hospital, Singapore

Sponsors
All Listed Sponsors
lead

MerLion Pharmaceuticals GmbH

INDUSTRY

NCT00722735 - Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) | Biotech Hunter | Biotech Hunter